Heparin Mapping Using Heparin Lyases and the Generation of a Novel Low Molecular Weight Heparin

Overview

Journal J Med Chem

Publisher American Chemical Society

Specialty Chemistry

Date 2010 Dec 21

PMID 21166465

Citations 33

Authors

Zhongping Xiao

Britney R Tappen

Mellisa Ly

Wenjing Zhao

Lauren P Canova

Huashi Guan

Robert J Linhardt

Affiliations

Soon will be listed here.

Abstract

Seven pharmaceutical heparins were investigated by oligosaccharide mapping by digestion with heparin lyase 1, 2, or 3, followed by high performance liquid chromatography analysis. The structure of one of the prepared mapping standards, ΔUA-Gal-Gal-Xyl-O-CH(2)CONHCH(2)COOH (where ΔUA is 4-deoxy-α-l-threo-hex-4-eno-pyranosyluronic acid, Gal is β-d-galactpyranose, and Xyl is β-d-xylopyranose) released from the linkage region using either heparin lyase 2 or heparin lyase 3 digestion, is reported for the first time. A size-dependent susceptibility of site cleaved by heparin lyase 3 was also observed. Heparin lyase 3 acts on the undersulfated domains of the heparin chain and does not cleave the linkages within heparin's antithrombin III binding site. Thus, a novel low molecular weight heparin (LMWH) is afforded on heparin lyase 3 digestion of heparin due to this unique substrate specificity, which has anticoagulant activity comparable to that of currently available LMWH.

Citing Articles

Switching mechanism from AR to EGFR signaling via 3-O-sulfated heparan sulfate in castration-resistant prostate cancer.

Ota H, Sato H, Mizumoto S, Wakai K, Yoneda K, Yamamoto K Sci Rep. 2023; 13(1):11618.

PMID: 37463954 PMC: 10354070. DOI: 10.1038/s41598-023-38746-x.

Biotechnologically produced chitosans with nonrandom acetylation patterns differ from conventional chitosans in properties and activities.

Sreekumar S, Wattjes J, Niehues A, Mengoni T, Mendes A, Morris E Nat Commun. 2022; 13(1):7125.

PMID: 36418307 PMC: 9684148. DOI: 10.1038/s41467-022-34483-3.

Influence of saccharide modifications on heparin lyase III substrate specificities.

Wu J, Chopra P, Boons G, Zaia J Glycobiology. 2021; 32(3):208-217.

PMID: 33822051 PMC: 8966481. DOI: 10.1093/glycob/cwab023.

The 3--sulfation of heparan sulfate modulates protein binding and lyase degradation.

Chopra P, Joshi A, Wu J, Lu W, Yadavalli T, Wolfert M Proc Natl Acad Sci U S A. 2021; 118(3).

PMID: 33441484 PMC: 7826381. DOI: 10.1073/pnas.2012935118.

Enzyme immobilization offers a robust tool to scale up the production of longer, diverse, natural glycosaminoglycan oligosaccharides.

Alabbas A, Desai U Glycobiology. 2020; 30(10):768-773.

PMID: 32193533 PMC: 7526740. DOI: 10.1093/glycob/cwaa027.

References

Linhardt R, Loganathan D, Al-Hakim A, Wang H, Walenga J, Hoppensteadt D . Oligosaccharide mapping of low molecular weight heparins: structure and activity differences. J Med Chem. 1990; 33(6):1639-45. DOI: 10.1021/jm00168a017. View

Nader H, Porcionatto M, Tersariol I, Pinhal M, Oliveira F, Moraes C . Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. J Biol Chem. 1990; 265(28):16807-13. View

Ly M, Laremore T, Linhardt R . Proteoglycomics: recent progress and future challenges. OMICS. 2010; 14(4):389-99. PMC: 3133783. DOI: 10.1089/omi.2009.0123. View

Linhardt R, Galliher P, Cooney C . Polysaccharide lyases. Appl Biochem Biotechnol. 1986; 12(2):135-76. DOI: 10.1007/BF02798420. View

Dietrich C, Silva M, Michelacci Y . Sequential degradation of heparin in Flavobacterium heparinum. Purification and properties of five enzymes involved in heparin degradation. J Biol Chem. 1973; 248(18):6408-15. View

Ly M, Wang Z, Laremore T, Zhang F, Zhong W, Pu D . Analysis of E. coli K5 capsular polysaccharide heparosan. Anal Bioanal Chem. 2010; 399(2):737-45. PMC: 3390146. DOI: 10.1007/s00216-010-3679-7. View

Shaya D, Zhao W, Garron M, Xiao Z, Cui Q, Zhang Z . Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate. J Biol Chem. 2010; 285(26):20051-61. PMC: 2888417. DOI: 10.1074/jbc.M110.101071. View

Jandik K, Gu K, Linhardt R . Action pattern of polysaccharide lyases on glycosaminoglycans. Glycobiology. 1994; 4(3):289-96. DOI: 10.1093/glycob/4.3.289. View

Turnbull J . Oligosaccharide mapping and sequence analysis of glycosaminoglycans. Methods Mol Biol. 1993; 19:253-67. DOI: 10.1385/0-89603-236-1:253. View

10.

Turnbull J, Hopwood J, Gallagher J . A strategy for rapid sequencing of heparan sulfate and heparin saccharides. Proc Natl Acad Sci U S A. 1999; 96(6):2698-703. PMC: 15832. DOI: 10.1073/pnas.96.6.2698. View

11.

Yamada S, Sakamoto K, Tsuda H, Yoshida K, Sugiura M, Sugahara K . Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin. Biochemistry. 1999; 38(2):838-47. DOI: 10.1021/bi981889n. View

12.

Yang V, Linhardt R, Bernstein H, Cooney C, Langer R . Purification and characterization of heparinase from Flavobacterium heparinum. J Biol Chem. 1985; 260(3):1849-57. View

13.

Liu J, Desai U, Han X, Toida T, Linhardt R . Strategy for the sequence analysis of heparin. Glycobiology. 1995; 5(8):765-74. DOI: 10.1093/glycob/5.8.765. View

14.

Laremore T, Ly M, Solakyildirim K, Zagorevski D, Linhardt R . High-resolution preparative separation of glycosaminoglycan oligosaccharides by polyacrylamide gel electrophoresis. Anal Biochem. 2010; 401(2):236-41. PMC: 2860026. DOI: 10.1016/j.ab.2010.03.004. View

15.

Shibata S, Midura R, Hascall V . Structural analysis of the linkage region oligosaccharides and unsaturated disaccharides from chondroitin sulfate using CarboPac PA1. J Biol Chem. 1992; 267(10):6548-55. View

16.

Sugahara K, Tsuda H, Yoshida K, Yamada S, De Beer T, Vliegenthart J . Structure determination of the octa- and decasaccharide sequences isolated from the carbohydrate-protein linkage region of porcine intestinal heparin. J Biol Chem. 1995; 270(39):22914-23. DOI: 10.1074/jbc.270.39.22914. View

17.

Shaya D, Tocilj A, Li Y, Myette J, Venkataraman G, Sasisekharan R . Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J Biol Chem. 2006; 281(22):15525-35. DOI: 10.1074/jbc.M512055200. View

18.

Rice K, Rottink M, Linhardt R . Fractionation of heparin-derived oligosaccharides by gradient polyacrylamide-gel electrophoresis. Biochem J. 1987; 244(3):515-22. PMC: 1148026. DOI: 10.1042/bj2440515. View

19.

Linhardt R, Rice K, Kim Y, Lohse D, Wang H, Loganathan D . Mapping and quantification of the major oligosaccharide components of heparin. Biochem J. 1988; 254(3):781-7. PMC: 1135151. DOI: 10.1042/bj2540781. View

20.

Linhardt R, Fitzgerald G, Cooney C, Langer R . Mode of action of heparin lyase on heparin. Biochim Biophys Acta. 1982; 702(2):197-203. DOI: 10.1016/0167-4838(82)90503-9. View